Ageless Beauty · Medical Aesthetics & Beauty Industry Cooperation Proposal
✓ 已验证B2B2C Cooperation
China's medical aesthetics market is ~¥370B in 2025, projected to exceed ¥600B by 2030, CAGR 15-20%. Consumers want quantifiable results, customizable plans, and predictable risk--exactly what genomic dry-computing excels at. We do not touch clinical practice, wet-lab, skincare recommendations, or sequencing. We are the computing brain that translates A/T/C/G into quantifiable beauty solutions. B2B2C model: we are your institution's computing backbone, never facing the C-end directly.
Computing Infrastructure, Not a Competitor
We do not touch medical aesthetics, clinical practice, wet-lab, skincare recommendations, or sequencing. We do bioinformatics dry-computing: the computing brain that translates A/T/C/G into quantifiable beauty solutions.
Building an in-house dry-computing team needs 3-5 people, ~¥1.5-3M/year; when annual demand <1,000 cases, partnering with us costs significantly less. Bio-AI tools have SOTA updates every quarter--in-house R&D rolling investment is large. We have already sedimented full-stack tracking and validation capability.
Three Reader Types
Institution Decision-Maker
Evaluate market window and differentiation--gene-level precision aesthetics is the next decade's growth engine; access cutting-edge tech at low cost
Technical Lead
Evaluate computing capability and pipeline status--four dry-computing pipelines (A/B/C verified, D exploratory), tool stack and population calibration
Marketing Lead
Evaluate product matrix and retail pricing--white-label reports under your brand, B2B2C packages from basic to flagship
Ready-to-Deploy Business Integration
Sign today, deliver next week--validated, proven, deliverable engineering capability
| Pipeline | What to Tell Your Customer | Status | Delivery Form | Est. Consumer Price |
|---|---|---|---|---|
| 管线 A Aesthetic Phenotype PRS | Your genetic beauty profile--collagen loss rate, photoaging sensitivity, hair loss risk, pigmentation, quantified as percentile ranking | ✓ 已验证 | White-label report | ¥3,000-6,500 |
| 管线 B Anti-Aging Peptide & Protein Engineering | Molecular-level R&D backbone for your active ingredients--MMPs inhibitors, Sirtuin activators, collagen engineering | ✓ 已验证 | Project-based | ¥15,000-50,000 |
| 管线 C Skin Microbiome × Host Gene | Your skin state is a symbiotic result of genes and microbiome--16S + HLA/FLG cross-mining | ✓ 已验证 | Report + continuous tracking | ¥3,000-6,500 |
| 管线 D Hair Follicle Induction | From repair to regeneration--five-factor combination induces new follicles on hairless skin | 🔬 探索性 | ARM licensing model | No market benchmark (blue ocean) |
Two Cooperation Modes
Standard menu · No API mode
White-label Report
Report under your brand, content by us
3-5 business days, bilingual CN/EN
Project-based
Custom R&D for proprietary active ingredients / collagen engineering
2-8 weeks, with candidate report
B2B2C Packages
Consumer price space (high end) · Our partner price negotiated separately
| Package | Includes | Est. Consumer Price | Retail Suggestion (high end) |
|---|---|---|---|
| Ageless Beauty Basic | WGS interpretation + aesthetic PRS (5 traits) | ¥3,000-5,000/person | ¥5,000/person |
| Ageless Beauty Advanced | Basic + skin microbiome joint analysis | ¥6,000-10,000/person | ¥10,000/person |
| Ageless Beauty Flagship | Advanced + personalized peptide candidates (lite) | ¥25,000-40,000/person | ¥40,000/person |
Partner Profile
- ·High-end private medical aesthetics
- ·Anti-aging centers / longevity clinics
- ·Hair transplant institutions
- ·Efficacy skincare brand R&D
Deployment Rhythm
Five-Layer Tech Stack
Validated and deliverable
| Layer | Name | Content | Status |
|---|---|---|---|
| L1 | Source Code | 3B base-pair WGS, DiVoGenome three-model cross-interpretation (based on 636 Chinese pan-genome) | ✓ 已验证 |
| L2 | Molecular Self-Portrait | DiVoFold5 builds 3D structure for each variant protein, pLDDT 95.4 / ipTM 0.977 | ✓ 已验证 |
| L3 | Virtual Cell | DiVoCell + DiVoSignal--drag in a drug, change a gene parameter, see how pathways rewire | 🔬 探索性 |
| L4 | Time Dimension | GrimAge + DunedinPACE epigenetic clocks, read aging curves like stock K-lines | ✓ 已验证 |
| L5 | Cross-Generation View | Family gene map, recessive pathogenic variants highlighted | ✓ 已验证 |
Tech Foundation Matrix · Red-Blue Print
✓ Self-developed verified = competitive moat · ◈ Self-developed exploratory · Outsourced = world-class equipment
| Tech Domain | Representative Capability | Status |
|---|---|---|
| Sequencing & Omics | WGS / WES / single-cell / spatial transcriptomics / metagenomics / epigenetics | Outsourced (P2, world-class equipment) |
| Computing & AI (self-developed core) | DiVoFold5 structure prediction (pLDDT 95.4) · DiVoGenome three-model cross · RNALens mRNA design (Spearman 0.92) · neoantigen 8-step pipeline · CAR-T Binder design | ✓ Self-developed verified (P0) |
| Computing & AI (exploratory) | DiVoCell multi-cell simulation · DiVoSignal signaling pathways | ◈ Self-developed exploratory (P0) |
| Hardware & Compute | RVDon RISC-V GPGPU (Protenix acceleration base) | ✓ Self-developed verified (P0) |
| Engineering & Delivery | Pipeline orchestration (Nextflow/Snakemake) · Docker containerized delivery · bilingual CN/EN reports · Agent dialogue engine | ✓ Self-developed verified / ◈ In development |
Ready-to-Use Dry-Computing Services
8 verified + 1 exploratory + 1 conceptual · proof of strength
| # | Service | Tag | Status | Key Metric |
|---|---|---|---|---|
| 1 | Tumor Neoantigen mRNA Vaccine 8-Step Pipeline | Flagship | ✓ 已验证 | 45 candidates · 17 Tier-1 · IC50 min 10.1 nM · pLDDT 95.4 |
| 2 | pMHC 3D Structure Prediction + Docking Validation | Core differentiator | ✓ 已验证 | pLDDT 95.4 · ipTM 0.977 · 5 docking sets |
| 3 | Genome Interpretation Report (bilingual CN/EN) | General service | ✓ 已验证 | 12+ batches · MD/HTML/PDF |
| 4 | HLA Typing (dual-tool cross-validation) | Entry service | ✓ 已验证 | 65+25 allele · OptiType+Polysolver |
| 5 | mRNA Sequence Optimization (RNALens) | Self-developed fine-tune | ✓ 已验证 | Spearman 0.92 · CAI 0.7->0.95 |
| 6 | CAR-T Cell Therapy Computing | New service | ✓ 已验证 | RFdiffusion+MPNN · pLDDT 95.4 |
| 7 | Aesthetic Phenotype PRS · Genetic Beauty Profile | Ageless Beauty | ✓ 已验证 | 5-target PRS · PRSice-2+PRS-CS · GVM+NyuWa calibration |
| 8 | Anti-Aging Peptide & Protein Engineering | Ageless Beauty | ✓ 已验证 | pLDDT 95.4 · Pro-Prime ΔΔG · BoltzGen 5 weights |
| 9 | Skin Microbiome × Host Gene Joint Mining | Ageless Beauty | ✓ 已验证 | DADA2+MGnify · ANNOVAR+HLA · SILVA 138.2 |
| 10 | Hair Follicle Induction · Five-Factor Combination | Ageless Beauty | 🔬 探索性 | Protenix pLDDT 95.4 · mRNA delivery design ready |
Items 7-10 (Ageless Beauty four) directly serve medical aesthetics / beauty partners; items 1, 2, 6 are B2B services for pharma / onco-immunology R&D, listed here only to prove the same computing base is cross-domain reusable.
Capability Boundaries
What we can and cannot do, stated clearly
✓ What We Can Do
✗ What We Do Not Do
All capabilities marked at three levels: ✓ verified / ◈ has code unverified / ◎ framework only.
What Powers Us
One full-stack technology system powers all services--from silicon to your scenario.
Algorithm -> Model -> Chip -> Hardware Deployment · Full-Stack Technology System
Related Pages
Dive deeper into Ageless Beauty and the technology system